Your browser doesn't support javascript.
loading
First Clinical Experience With [68Ga]Ga-FAPI-46-PET/CT Versus [18F]F-FDG PET/CT for Nodal Staging in Cervical Cancer.
Wegen, Simone; Roth, Katrin Sabine; Weindler, Jasmin; Claus, Karina; Linde, Philipp; Trommer, Maike; Akuamoa-Boateng, Dennis; van Heek, Lutz; Baues, Christian; Schömig-Markiefka, Birgid; Schomäcker, Klaus; Fischer, Thomas; Drzezga, Alexander; Kobe, Carsten; Köhler, Christhardt; Marnitz, Simone.
Affiliation
  • Wegen S; From the Department of Radiation Oncology, Cyberknife and Radiotherapy, University Hospital Cologne.
  • Roth KS; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne.
  • Weindler J; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne.
  • Claus K; From the Department of Radiation Oncology, Cyberknife and Radiotherapy, University Hospital Cologne.
  • Linde P; From the Department of Radiation Oncology, Cyberknife and Radiotherapy, University Hospital Cologne.
  • Trommer M; From the Department of Radiation Oncology, Cyberknife and Radiotherapy, University Hospital Cologne.
  • Akuamoa-Boateng D; From the Department of Radiation Oncology, Cyberknife and Radiotherapy, University Hospital Cologne.
  • van Heek L; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne.
  • Baues C; From the Department of Radiation Oncology, Cyberknife and Radiotherapy, University Hospital Cologne.
  • Schömig-Markiefka B; Institute for Pathology, University Hospital of Cologne, Cologne.
  • Schomäcker K; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne.
  • Fischer T; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne.
  • Kobe C; Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne.
  • Köhler C; Department of Special Operative and Oncologic Gynecology, Asklepios-Clinic Hamburg-Altona, Asklepios Hospital Group, Hamburg, Germany.
  • Marnitz S; From the Department of Radiation Oncology, Cyberknife and Radiotherapy, University Hospital Cologne.
Clin Nucl Med ; 48(2): 150-155, 2023 Feb 01.
Article in En | MEDLINE | ID: mdl-36607364
INTRODUCTION: In several solid tumors, fibroblast activation protein (FAP) is overexpressed by cancer-associated fibroblasts in the tumor microenvironment. Preliminary evidence suggests that detection and staging are feasible with PET/CT imaging using [68Ga]-radiolabeled inhibitors of FAP also in cervical cancer (CC). Our study aims to explore the accuracy of [68Ga]Ga-fibroblast activation protein inhibitor (FAPI)-46 PET/CT and [18F]F-FDG PET/CT compared with histopathological results of surgical lymph node (LN) staging before primary chemoradiation. METHODS: Seven consecutive women with treatment-naive and biopsy-proven locally advanced CC underwent both whole-body [68Ga]Ga-FAPI-46- and [18F]F-FDG PET/CT, for imaging nodal staging before systematic laparoscopic lymphadenectomy of the pelvic and para-aortic region. Location and number of suspicious LNs in PET imaging were recorded and compared with the results of histopathological analysis, including immunohistochemical staining for FAP. RESULTS: All 7 patients had focal uptake above background in their tumor lesions in [68Ga]Ga-FAPI-46 PET/CT. [68Ga]Ga-FAPI-46 PET/CT showed a higher tumor-to-background ratio (TBR) in primary tumor as well as in LN metastasis. Median TBRmax values using liver were 32.02 and 5.15 for [68Ga]Ga-FAPI-46 PET/CT and [18F]F-FDG PET/CT, respectively. Median TBRmax using blood pool was 18.45 versus 6.85 for [68Ga]Ga-FAPI-46 PET/CT and [18F]F-FDG PET/CT, respectively. Higher TBR also applies for nodal metastasis: TBRmax was 14.55 versus 1.39 (liver) and 7.97 versus 1.8 (blood pool) for [68Ga]Ga-FAPI-46 PET/CT and [18F]F-FDG PET/CT, respectively. Overall, [68Ga]Ga-FAPI-46 PET/CT detected more lesions compared with [18F]F-FDG PET/CT. Following surgical staging, a total of 5 metastatic LNs could be pathologically confirmed, of which 2 and 4 were positive by [18F]F-FDG PET/CT and [68Ga]Ga-FAPI-46 PET/CT, respectively. CONCLUSION: [68Ga]Ga-FAPI-46 PET/CT seems useful to improve detection of nodal metastasis in patients with CCs. Future studies should aim to compare [68Ga]Ga-FAPI-46 PET/CT to surgical staging of pelvic and para-aortic LNs in patients with locally advanced CC.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Positron Emission Tomography Computed Tomography Limits: Female / Humans Language: En Journal: Clin Nucl Med Year: 2023 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Neoplasms / Positron Emission Tomography Computed Tomography Limits: Female / Humans Language: En Journal: Clin Nucl Med Year: 2023 Document type: Article Country of publication: United States